Medicare and Medicaid would cover weight-loss drugs like Wegovy and Ozempic under a new rule proposed by President Joe Biden on Tuesday, increasing access to the widely popular medications to millions of adults with obesity in the U.S., though the plan would likely face opposition under President-elect Donald Trump's second administration.

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage chronic conditions such as diabetes and heart disease and others to help them lose weight.

Weight-loss drugs like Ozempic and Wegovy are gaining popularity as quick fixes for shedding pounds. Known as GLP-1 agonists, these medications work by imitating a gut hormone that reduces hunger,

“I love Thanksgiving for the pumpkin pie — it's such a low-sugar dessert that it tends to be fine for your blood sugar,” Bensley tells PEOPLE. “Chocolate is okay, but just try to do it with your meal to keep that blood sugar stable.”

America's kitchen trash bins are receiving more unwanted food as appetites falter among people taking GLP-1 weight-loss meds, a new study shows.

Millions of Americans with obesity would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare and Medicaid under a new rule the Biden administration proposed Tuesday morning.

Millions of Americans could soon have access to weight-loss medications that some have called "miracle drugs."

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $ 35 billion proposal from the Biden administration is blessed by President-elect Donald Trump.